Orlistat use in overweight women with mild hypercholesterolemia

Int J Clin Pharmacol Res. 2002;22(3-4):85-8.

Abstract

In the present study, we investigated the effects of a 6-month treatment with orlistat on body weight and lipid profile in 27 overweight women (mean body mass index [BMI]: 27.5 kg/m2; median age: 38.4 years) with mild hypercholesterolemia (total cholesterol: 225 mg/dl; low-density lipoprotein cholesterol [LDL-C]: 162 mg/dl). Orlistat was administered three times per day in conjunction with a hypocaloric diet After 6 months of treatment, body weight decreased by 17.71% and BMI decreased by 18.54%, whereas there was a significant (p < 0.01) improvement in serum lipid levels (total cholesterol: -25.33% LDL-C: -30.86%, high-density lipoprotein cholesterol: +9.37%, triglycerides: -35.97%). In conclusion, orlistat in combination with a low-energy diet seems to have a beneficial effect on body weight and lipid profile in overweight women with mild hypercholesterolemia.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Anti-Obesity Agents / administration & dosage
  • Anti-Obesity Agents / therapeutic use*
  • Body Mass Index
  • Body Weight / drug effects
  • Cholesterol, LDL / blood
  • Diet, Reducing
  • Female
  • Humans
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / diet therapy
  • Hypercholesterolemia / drug therapy*
  • Lactones / administration & dosage
  • Lactones / therapeutic use*
  • Lipoproteins, HDL / blood
  • Middle Aged
  • Obesity / complications
  • Obesity / diet therapy
  • Obesity / drug therapy*
  • Orlistat
  • Treatment Outcome
  • Triglycerides / blood

Substances

  • Anti-Obesity Agents
  • Cholesterol, LDL
  • Lactones
  • Lipoproteins, HDL
  • Triglycerides
  • Orlistat